$2.7MSeries A, 26 March 2026
Series A to expand Hyderabad manufacturing and microbiome R&D.
- Amount
- $2.7M
- Stage
- Series A
- Announced
- 26 March 2026
- Lead
- AgriSURE Fund (NABVENTURES)
- Use of funds
- Series A to expand Hyderabad manufacturing and microbiome R&D.
- Checked
- Announced by the company
- Sources
- ELMED Life Sciences raises $2.7M Series A biovoicenews.com
ELMED Life Sciences raises $2.7M Series A inc42.com